FME — Fresenius Medical Care AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapSuper Stock

Annual income statement for Fresenius Medical Care AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	17,859	17,619	19,398	19,454	19,336
Cost of Revenue
Gross Profit	5,537	4,773	4,894	4,925	4,757
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	15,555	15,766	17,886	18,084	17,944
Operating Profit	2,304	1,852	1,512	1,369	1,392
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	1,936	1,572	1,219	1,033	1,057
Provision for Income Taxes
Net Income After Taxes	1,436	1,219	894	732	741
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,164	969	673	499	538
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,164	969	673	499	538
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.72	3.38	2.15	2.91	2.29
Dividends per Share